These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35. The clinical use of levodopa in the treatment of Parkinson's disease. McDowell FH, Markham CH, Lee JE, Treciokas LJ, Ansel RD. Contemp Neurol Ser; 1971 Nov; 8():175-201. PubMed ID: 4950056 [No Abstract] [Full Text] [Related]
36. Variation of levodopa metabolism with gastrointestinal absorption site. Sandler M, Ruthven CR, Goodwin BL, Hunter KR, Stern GM. Lancet; 1974 Feb 16; 1(7851):238-40. PubMed ID: 4130247 [No Abstract] [Full Text] [Related]
37. Modification of L-dopa therapy of Parkinsonism by alpha-methyldopa hydrazine (MK-486). Yahr MD, Duvoisin RC, Mendoza MR, Schear MJ, Barrett RE. Trans Am Neurol Assoc; 1971 Feb 16; 96():55-8. PubMed ID: 5159129 [No Abstract] [Full Text] [Related]
38. [L-dopa treatment of parkinsonism]. Szulc-Kuberska J, Niewodniczy A, Poźniak-Patewicz E, Wolczyk-Orzechowska M. Neurol Neurochir Pol; 1973 Feb 16; 7(1):63-8. PubMed ID: 4511385 [No Abstract] [Full Text] [Related]
40. Analysis of deaths in Parkinson patients on long-term levodopa therapy. Cote L, Yahr MD, Duvoisin RC, Wolf A, Marksbery W. Trans Am Neurol Assoc; 1970 Feb 16; 95():73-7. PubMed ID: 4998770 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]